Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorGRIMALDI-BENSOUDA, Lamiae
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBEGAUD, Bernard
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBENICHOU, Jacques
dc.contributor.authorNORDON, Clementine
dc.contributor.authorDIALLA, Olivia
dc.contributor.authorMORISOT, Nicolas
dc.contributor.authorHAMON, Yann
dc.contributor.authorCOTTIN, Yves
dc.contributor.authorSERRANO, Elie
dc.contributor.authorABENHAIM, Lucien
dc.contributor.authorTOUZE, Emmanuel
dc.date.accessioned2021-04-19T09:06:17Z
dc.date.available2021-04-19T09:06:17Z
dc.date.issued2021-02-18
dc.identifier.issn2045-2322 (Electronic) 2045-2322 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26960
dc.description.abstractEnPharmacovigilance reports of cerebral and cardiovascular events in those who use decongestants have triggered alerts related to their use. We aimed to assess the risk of stroke and myocardial infarction (MI) associated with the use of decongestants. We conducted a nested case-crossover study of patients with incident stroke and MI identified in France between 2013 and 2016 in two systematic disease registries. Decongestant use in the three weeks preceding the event was assessed using a structured telephone interview. Conditional logistic multivariable models were used to estimate the odds of incident MI and stroke, also accounting for transient risk factors and comparing week 1 (index at-risk time window, immediately preceding the event) to week 3 (reference). Time-invariant risk factors were controlled by design. In total, 1394 patients with MI and 1403 patients with stroke, mainly 70 years old or younger, were interviewed, including 3.2% who used decongestants during the three weeks prior to the event (1.0% definite exposure in the index at-risk time window, 1.1% in the referent time window; adjusted odds ratio (aOR), 0.78; 95%CI, 0.43–1.42). Secondary analysis yielded similar results for individual events (MI/stroke). We observed no increased risk of MI or stroke for patients 70 years of age and younger without previous MI or stroke who used decongestants.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enCardiology
dc.subject.enMedical research
dc.subject.enNeurology
dc.subject.enRisk factors
dc.title.enDecongestant use and the risk of myocardial infarction and stroke: a case-crossover study
dc.title.alternativeSci Repen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1038/s41598-021-83718-8en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33603081en_US
bordeaux.journalScientific Reportsen_US
bordeaux.page4160en_US
bordeaux.volume11en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03201710
hal.version1
hal.date.transferred2021-04-19T09:06:22Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Scientific%20Reports&rft.date=2021-02-18&rft.volume=11&rft.issue=1&rft.spage=4160&rft.epage=4160&rft.eissn=2045-2322%20(Electronic)%202045-2322%20(Linking)&rft.issn=2045-2322%20(Electronic)%202045-2322%20(Linking)&rft.au=GRIMALDI-BENSOUDA,%20Lamiae&BEGAUD,%20Bernard&BENICHOU,%20Jacques&NORDON,%20Clementine&DIALLA,%20Olivia&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record